Literature DB >> 25330223

Effect of mismatching for mHA UTA2-1 on clinical outcome after HLA-identical sibling donor allo-SCT.

A Bosch-Vizcaya1, R Rodriguez-Romanos1, J B Nieto2, R de la Cámara3, S Brunet4, C Vallejo5, G Osca-Gelis1, C Martínez-Laperche6, I Buño6, Á Urbano-Ispizúa7, M González8, A Jiménez-Velasco9, D Gallardo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25330223     DOI： 10.1038/bmt.2014.234

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  Absence of statistically significant correlation between disparity for the minor histocompatibility antigen-HA-1 and outcome after allogeneic hematopoietic cell transplantation.

Authors:  M T Lin; T Gooley; J A Hansen; L H Tseng; E G Martin; K Singleton; A G Smith; E Mickelson; E W Petersdorf; P J Martin
Journal:  Blood       Date:  2001-11-15       Impact factor: 22.113

2.  Expanding the immunotherapeutic potential of minor histocompatibility antigens.

Authors:  Eric Spierings; Els Goulmy
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

3.  Clinical outcome after sex-mismatched allogeneic stem cell transplantation from human lymphocyte antigen-identical sibling donors: influence of stem cell source.

Authors:  D Gallardo; A Pérez-García; R de la Cámara; A Iriondo; A Jiménez-Velasco; A Torres; S Brunet; A Urbano-Ispizúa; C Vallejo; M Encuentra; D Caballero; I Espigado; D Serrano; C Barrenetxea; J M Ribera; J de la Rubia
Journal:  Leukemia       Date:  2006-05-25       Impact factor: 11.528

4.  Minor histocompatibility antigen HA-8 mismatch and clinical outcome after HLA-identical sibling donor allogeneic stem cell transplantation.

Authors:  Arianne Pérez-García; Rafael De la Cámara; Antonio Torres; Marcos González; Antonio Jiménez; David Gallardo
Journal:  Haematologica       Date:  2005-12       Impact factor: 9.941

5.  Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation.

Authors:  D Gallardo; J I Aróstegui; A Balas; A Torres; D Caballero; E Carreras; S Brunet; A Jiménez; R Mataix; D Serrano; C Vallejo; G Sanz; C Solano; M Rodríguez-Luaces; J Marín; J Baro; C Sanz; J Román; M González; J Martorell; J Sierra; C Martín; R de la Cámara; A Grañena
Journal:  Br J Haematol       Date:  2001-09       Impact factor: 6.998

6.  Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia.

Authors:  W A Erik Marijt; Mirjam H M Heemskerk; Freke M Kloosterboer; Els Goulmy; Michel G D Kester; Menno A W G van der Hoorn; Simone A P van Luxemburg-Heys; Manja Hoogeboom; Tuna Mutis; Jan Wouter Drijfhout; Jon J van Rood; Roel Willemze; J H Frederik Falkenburg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

7.  Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.

Authors:  Eric Spierings; Yeung-Hyen Kim; Matthijs Hendriks; Eric Borst; Ruhena Sergeant; Angelica Canossi; Machteld Oudshoorn; Pascale Loiseau; Harry Dolstra; Miroslaw Markiewicz; Mary S Leffell; Noemi Pereira; Brigitte Kircher; Hannu Turpeinen; Jean-François Eliaou; Thibaut Gervais; David Laurin; Jürgen Enczmann; Miryam Martinetti; Jackie Thomson; Fatma Oguz; Stella Santarone; Jukka Partanen; Urszula Siekiera; Emilio Paolo Alessandrino; Sevgi Kalayoglu; Ronald Brand; Els Goulmy
Journal:  Biol Blood Marrow Transplant       Date:  2013-06-10       Impact factor: 5.742

Review 8.  Graft-versus-leukemia effects of transplantation and donor lymphocytes.

Authors:  Hans-Jochem Kolb
Journal:  Blood       Date:  2008-12-01       Impact factor: 22.113

9.  A uniform genomic minor histocompatibility antigen typing methodology and database designed to facilitate clinical applications.

Authors:  Eric Spierings; Jos Drabbels; Matthijs Hendriks; Jos Pool; Marijke Spruyt-Gerritse; Frans Claas; Els Goulmy
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

10.  Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1.

Authors:  R Oostvogels; M C Minnema; M van Elk; R M Spaapen; G D te Raa; B Giovannone; A Buijs; D van Baarle; A P Kater; M Griffioen; E Spierings; H M Lokhorst; T Mutis
Journal:  Leukemia       Date:  2012-10-01       Impact factor: 11.528
  10 in total
  1 in total

Review 1.  Applying genomics in heart transplantation.

Authors:  Brendan J Keating; Alexandre C Pereira; Michael Snyder; Brian D Piening
Journal:  Transpl Int       Date:  2018-02-12       Impact factor: 3.782
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.